ONCY Annual Operating Profit
-$25.03 M
-$4.33 M-20.93%
31 December 2023
Summary:
As of January 23, 2025, ONCY annual operaing income is -$25.03 million, with the most recent change of -$4.33 million (-20.93%) on December 31, 2023. During the last 3 years, it has fallen by -$6.02 million (-31.70%). ONCY annual operating profit is now -6339.94% below its all-time high of -$388.60 thousand, reached on December 31, 1999.ONCY Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Quarterly Operating Profit
-$7.25 M
-$1.47 M-25.36%
30 September 2024
Summary:
As of January 23, 2025, ONCY quarterly operating income is -$7.25 million, with the most recent change of -$1.47 million (-25.36%) on September 30, 2024. Over the past year, it has increased by +$978.40 thousand (+11.88%). ONCY quarterly operating profit is now -2477.79% below its all-time high of -$281.40 thousand, reached on March 31, 2000.ONCY Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY TTM Operating Profit
-$26.01 M
+$978.40 K+3.63%
30 September 2024
Summary:
As of January 23, 2025, ONCY TTM operating income is -$26.01 million, with the most recent change of +$978.40 thousand (+3.63%) on September 30, 2024. Over the past year, it has dropped by -$1.21 million (-4.90%). ONCY TTM operating profit is now -9143.25% below its all-time high of -$281.40 thousand, reached on March 31, 2000.ONCY TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.9% | +11.9% | -4.9% |
| 3 y3 years | -31.7% | -15.8% | -26.2% |
| 5 y5 years | -87.8% | -15.8% | -26.2% |
ONCY Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.9% | at low | -56.3% | +11.9% | -28.4% | +3.6% |
| 5 y | 5-year | -63.0% | at low | -81.3% | +11.9% | -69.4% | +3.6% |
| alltime | all time | -6339.9% | +31.8% | -2477.8% | +36.7% | -9143.3% | +34.2% |
Oncolytics Biotech Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.25 M(+25.4%) | -$26.01 M(-3.6%) |
| June 2024 | - | -$5.79 M(-10.6%) | -$26.99 M(+1.7%) |
| Mar 2024 | - | -$6.47 M(-0.5%) | -$26.52 M(+6.0%) |
| Dec 2023 | -$25.03 M(+20.9%) | -$6.50 M(-21.0%) | -$25.03 M(+1.0%) |
| Sept 2023 | - | -$8.23 M(+54.7%) | -$24.80 M(+16.9%) |
| June 2023 | - | -$5.32 M(+6.9%) | -$21.20 M(+2.9%) |
| Mar 2023 | - | -$4.98 M(-20.5%) | -$20.61 M(-0.0%) |
| Dec 2022 | -$20.69 M(-1.1%) | -$6.26 M(+35.0%) | -$20.61 M(+1.7%) |
| Sept 2022 | - | -$4.64 M(-1.9%) | -$20.27 M(-1.2%) |
| June 2022 | - | -$4.73 M(-5.0%) | -$20.51 M(-3.5%) |
| Mar 2022 | - | -$4.98 M(-15.8%) | -$21.26 M(+1.5%) |
| Dec 2021 | -$20.93 M(+10.1%) | -$5.91 M(+21.0%) | -$20.93 M(-1.3%) |
| Sept 2021 | - | -$4.89 M(-10.7%) | -$21.21 M(+0.7%) |
| June 2021 | - | -$5.48 M(+17.6%) | -$21.06 M(+7.5%) |
| Mar 2021 | - | -$4.66 M(-24.8%) | -$19.59 M(+2.8%) |
| Dec 2020 | -$19.00 M(+23.8%) | -$6.19 M(+30.7%) | -$19.05 M(+5.7%) |
| Sept 2020 | - | -$4.74 M(+18.4%) | -$18.03 M(+13.1%) |
| June 2020 | - | -$4.00 M(-2.8%) | -$15.94 M(+0.7%) |
| Mar 2020 | - | -$4.12 M(-20.4%) | -$15.83 M(+3.1%) |
| Dec 2019 | -$15.35 M(+15.2%) | -$5.17 M(+95.6%) | -$15.35 M(+7.1%) |
| Sept 2019 | - | -$2.64 M(-32.1%) | -$14.33 M(+0.3%) |
| June 2019 | - | -$3.89 M(+6.9%) | -$14.29 M(+7.8%) |
| Mar 2019 | - | -$3.64 M(-12.3%) | -$13.25 M(-0.6%) |
| Dec 2018 | -$13.33 M(+10.7%) | -$4.15 M(+59.8%) | -$13.33 M(+4.0%) |
| Sept 2018 | - | -$2.60 M(-9.0%) | -$12.82 M(+1.4%) |
| June 2018 | - | -$2.85 M(-23.2%) | -$12.64 M(-3.0%) |
| Mar 2018 | - | -$3.72 M(+2.0%) | -$13.03 M(+8.5%) |
| Dec 2017 | -$12.04 M(+4.3%) | -$3.65 M(+50.5%) | -$12.01 M(-2.2%) |
| Sept 2017 | - | -$2.42 M(-25.3%) | -$12.28 M(-1.3%) |
| June 2017 | - | -$3.24 M(+20.4%) | -$12.43 M(+10.8%) |
| Mar 2017 | - | -$2.69 M(-31.2%) | -$11.22 M(-2.5%) |
| Dec 2016 | -$11.55 M(+5.9%) | -$3.92 M(+51.9%) | -$11.50 M(+12.4%) |
| Sept 2016 | - | -$2.58 M(+27.0%) | -$10.23 M(+3.8%) |
| June 2016 | - | -$2.03 M(-31.8%) | -$9.86 M(-10.3%) |
| Mar 2016 | - | -$2.98 M(+12.5%) | -$10.99 M(+0.6%) |
| Dec 2015 | -$10.90 M(-36.0%) | -$2.65 M(+20.2%) | -$10.93 M(-6.1%) |
| Sept 2015 | - | -$2.20 M(-30.5%) | -$11.63 M(-15.3%) |
| June 2015 | - | -$3.17 M(+8.7%) | -$13.73 M(-8.0%) |
| Mar 2015 | - | -$2.91 M(-13.1%) | -$14.93 M(-12.5%) |
| Dec 2014 | -$17.05 M(-26.5%) | -$3.35 M(-22.0%) | -$17.07 M(-11.6%) |
| Sept 2014 | - | -$4.30 M(-1.6%) | -$19.31 M(-8.1%) |
| June 2014 | - | -$4.37 M(-13.6%) | -$21.00 M(-3.0%) |
| Mar 2014 | - | -$5.05 M(-9.6%) | -$21.64 M(-6.8%) |
| Dec 2013 | -$23.21 M(-36.8%) | -$5.59 M(-6.7%) | -$23.22 M(-11.5%) |
| Sept 2013 | - | -$5.99 M(+19.6%) | -$26.23 M(-11.3%) |
| June 2013 | - | -$5.01 M(-24.5%) | -$29.59 M(-14.9%) |
| Mar 2013 | - | -$6.63 M(-22.9%) | -$34.75 M(-5.3%) |
| Dec 2012 | -$36.70 M | -$8.60 M(-7.9%) | -$36.68 M(-7.2%) |
| Sept 2012 | - | -$9.34 M(-8.2%) | -$39.55 M(+7.8%) |
| June 2012 | - | -$10.17 M(+18.8%) | -$36.67 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$8.56 M(-25.3%) | -$33.27 M(+15.3%) |
| Dec 2011 | -$29.05 M(+50.7%) | -$11.46 M(+77.2%) | -$28.86 M(+16.5%) |
| Sept 2011 | - | -$6.47 M(-4.4%) | -$24.77 M(+11.7%) |
| June 2011 | - | -$6.77 M(+62.9%) | -$22.17 M(+12.8%) |
| Mar 2011 | - | -$4.16 M(-43.7%) | -$19.66 M(+1.6%) |
| Dec 2010 | -$19.28 M(+34.9%) | -$7.38 M(+90.8%) | -$19.36 M(+14.4%) |
| Sept 2010 | - | -$3.87 M(-9.3%) | -$16.93 M(+9.1%) |
| June 2010 | - | -$4.26 M(+10.7%) | -$15.52 M(+3.6%) |
| Mar 2010 | - | -$3.85 M(-22.2%) | -$14.98 M(+4.5%) |
| Dec 2009 | -$14.30 M(-16.0%) | -$4.95 M(+101.2%) | -$14.33 M(+7.3%) |
| Sept 2009 | - | -$2.46 M(-34.0%) | -$13.36 M(-10.8%) |
| June 2009 | - | -$3.73 M(+16.5%) | -$14.97 M(-10.2%) |
| Mar 2009 | - | -$3.20 M(-19.6%) | -$16.68 M(-1.6%) |
| Dec 2008 | -$17.02 M(+8.0%) | -$3.98 M(-2.4%) | -$16.96 M(-6.3%) |
| Sept 2008 | - | -$4.07 M(-25.0%) | -$18.10 M(+2.7%) |
| June 2008 | - | -$5.43 M(+56.3%) | -$17.63 M(+10.0%) |
| Mar 2008 | - | -$3.48 M(-32.1%) | -$16.03 M(-1.6%) |
| Dec 2007 | -$15.76 M(+15.3%) | -$5.12 M(+42.0%) | -$16.30 M(-1.3%) |
| Sept 2007 | - | -$3.60 M(-6.0%) | -$16.52 M(+3.5%) |
| June 2007 | - | -$3.83 M(+2.4%) | -$15.97 M(+7.9%) |
| Mar 2007 | - | -$3.74 M(-29.9%) | -$14.79 M(+8.4%) |
| Dec 2006 | -$13.66 M(+24.3%) | -$5.34 M(+75.1%) | -$13.65 M(+11.1%) |
| Sept 2006 | - | -$3.05 M(+14.6%) | -$12.29 M(+1.7%) |
| June 2006 | - | -$2.66 M(+2.3%) | -$12.08 M(+3.0%) |
| Mar 2006 | - | -$2.60 M(-34.6%) | -$11.72 M(+6.1%) |
| Dec 2005 | -$10.99 M(+7.1%) | -$3.98 M(+40.0%) | -$11.05 M(+21.7%) |
| Sept 2005 | - | -$2.84 M(+23.1%) | -$9.07 M(+1.1%) |
| June 2005 | - | -$2.31 M(+19.7%) | -$8.98 M(+0.4%) |
| Mar 2005 | - | -$1.93 M(-3.8%) | -$8.94 M(-1.5%) |
| Dec 2004 | -$10.26 M(+116.8%) | -$2.00 M(-26.9%) | -$9.07 M(+6.3%) |
| Sept 2004 | - | -$2.74 M(+20.9%) | -$8.54 M(+20.0%) |
| June 2004 | - | -$2.27 M(+9.9%) | -$7.11 M(+16.6%) |
| Mar 2004 | - | -$2.06 M(+40.8%) | -$6.10 M(+27.7%) |
| Dec 2003 | -$4.74 M(+10.1%) | -$1.47 M(+11.1%) | -$4.78 M(+8.5%) |
| Sept 2003 | - | -$1.32 M(+5.1%) | -$4.40 M(-1.4%) |
| June 2003 | - | -$1.25 M(+70.2%) | -$4.47 M(+7.9%) |
| Mar 2003 | - | -$737.30 K(-32.5%) | -$4.14 M(-3.8%) |
| Dec 2002 | -$4.30 M(-6.7%) | -$1.09 M(-20.9%) | -$4.30 M(+0.8%) |
| Sept 2002 | - | -$1.38 M(+49.0%) | -$4.27 M(-7.0%) |
| June 2002 | - | -$927.80 K(+3.1%) | -$4.59 M(-1.9%) |
| Mar 2002 | - | -$900.10 K(-15.0%) | -$4.68 M(+1.6%) |
| Dec 2001 | -$4.61 M(+47.3%) | -$1.06 M(-37.9%) | -$4.61 M(+12.1%) |
| Sept 2001 | - | -$1.71 M(+67.5%) | -$4.11 M(+12.7%) |
| June 2001 | - | -$1.02 M(+23.4%) | -$3.65 M(-0.6%) |
| Mar 2001 | - | -$825.00 K(+47.2%) | -$3.67 M(+17.4%) |
| Dec 2000 | -$3.13 M(+705.2%) | -$560.30 K(-54.9%) | -$3.13 M(+21.8%) |
| Sept 2000 | - | -$1.24 M(+19.5%) | -$2.56 M(+94.1%) |
| June 2000 | - | -$1.04 M(+269.7%) | -$1.32 M(+369.7%) |
| Mar 2000 | - | -$281.40 K | -$281.40 K |
| Dec 1999 | -$388.60 K | - | - |
FAQ
- What is Oncolytics Biotech annual operaing income?
- What is the all time high annual operating profit for Oncolytics Biotech?
- What is Oncolytics Biotech annual operating profit year-on-year change?
- What is Oncolytics Biotech quarterly operating income?
- What is the all time high quarterly operating profit for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly operating profit year-on-year change?
- What is Oncolytics Biotech TTM operating income?
- What is the all time high TTM operating profit for Oncolytics Biotech?
- What is Oncolytics Biotech TTM operating profit year-on-year change?
What is Oncolytics Biotech annual operaing income?
The current annual operating profit of ONCY is -$25.03 M
What is the all time high annual operating profit for Oncolytics Biotech?
Oncolytics Biotech all-time high annual operaing income is -$388.60 K
What is Oncolytics Biotech annual operating profit year-on-year change?
Over the past year, ONCY annual operaing income has changed by -$4.33 M (-20.93%)
What is Oncolytics Biotech quarterly operating income?
The current quarterly operating profit of ONCY is -$7.25 M
What is the all time high quarterly operating profit for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly operating income is -$281.40 K
What is Oncolytics Biotech quarterly operating profit year-on-year change?
Over the past year, ONCY quarterly operating income has changed by +$978.40 K (+11.88%)
What is Oncolytics Biotech TTM operating income?
The current TTM operating profit of ONCY is -$26.01 M
What is the all time high TTM operating profit for Oncolytics Biotech?
Oncolytics Biotech all-time high TTM operating income is -$281.40 K
What is Oncolytics Biotech TTM operating profit year-on-year change?
Over the past year, ONCY TTM operating income has changed by -$1.21 M (-4.90%)